Improved methods of the contrast-enhanced ultrasound in patient with chronic viral hepatitis

Abstract

Rationale. The article presents the data obtained by an improved method of contrast-enhanced ultrasound (CEUS) in patients with chronic viral hepatitis.
 Methods. We compared the quantitative and qualitative CEUS parameters in 2 groups of patients: the 1st group was administered 2.5 ml of the contrast agent, and the 2nd group was administered 1.0 ml of the contrast agent.
 Results. The results showed that the quantitative parameters had no statistical differences in the arterial and portal phases.
 Conclusion. The parameters of the late venous phase were not clinically significant, since the study objective included the assessment of diffuse liver disease, not focal liver lesions.

The Capabilities of the Combi-Elasto and CEUS Ultrasound modes in the Diagnosis of Viral Hepatitis B

“…Результаты проведения УЗИ в режиме Combi-Elasto -степень фиброза F4 по шкале METAVIR (2,09), выраженная активность процесса(1,60), отсутствие стеатоза (0,54) на момент поступления Fig.1. Combi-Elasto results -fibrosis F4 of the METAVIR scale (2.09), expressed process activity (1.60), absence of steatosis (0.54) on admission of the liver parenchyma is up to 15 mm from the Glisson's capsule, asymmetrical decrease of the total intensity of the contrast enhancement; (в) late venous phase: half-time of washout 195.3 s, there are foci of heterogeneity and delayed washout of the contrast agent[13,14]…”